Cargando…
Safety and improved efficacy signals following gene therapy in childhood blindness caused by GUCY2D mutations
A first-in-human clinical trial of gene therapy in Leber congenital amaurosis due to mutations in the GUCY2D gene is underway, and early results are summarized. A recombinant adeno-associated virus serotype 5 (rAAV5) vector carrying the human GUCY2D gene was delivered by subretinal injection to one...
Autores principales: | Jacobson, Samuel G., Cideciyan, Artur V., Ho, Allen C., Peshenko, Igor V., Garafalo, Alexandra V., Roman, Alejandro J., Sumaroka, Alexander, Wu, Vivian, Krishnan, Arun K., Sheplock, Rebecca, Boye, Sanford L., Dizhoor, Alexander M., Boye, Shannon E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099775/ https://www.ncbi.nlm.nih.gov/pubmed/33997691 http://dx.doi.org/10.1016/j.isci.2021.102409 |
Ejemplares similares
-
Leber Congenital Amaurosis Due to GUCY2D Mutations: Longitudinal Analysis of Retinal Structure and Visual Function
por: Jacobson, Samuel G., et al.
Publicado: (2021) -
Night vision restored in days after decades of congenital blindness
por: Jacobson, Samuel G., et al.
Publicado: (2022) -
Functional study of two biochemically unusual mutations in GUCY2D Leber congenital amaurosis expressed via adenoassociated virus vector in mouse retinas
por: Boye, Sanford L., et al.
Publicado: (2016) -
Childhood-onset genetic cone-rod photoreceptor diseases and underlying pathobiology
por: Garafalo, Alexandra V., et al.
Publicado: (2021) -
GUCY2D mutations in retinal guanylyl cyclase 1 provide biochemical reasons for dominant cone–rod dystrophy but not for stationary night blindness
por: Peshenko, Igor V., et al.
Publicado: (2021)